nodes	percent_of_prediction	percent_of_DWPC	metapath
Leucovorin—TYMS—pancreatic cancer	0.399	1	CbGaD
Leucovorin—TYMS—Gemcitabine—pancreatic cancer	0.113	0.247	CbGbCtD
Leucovorin—TYMS—Fluorouracil—pancreatic cancer	0.0965	0.211	CbGbCtD
Leucovorin—ABCC3—Fluorouracil—pancreatic cancer	0.05	0.109	CbGbCtD
Leucovorin—ABCC4—Fluorouracil—pancreatic cancer	0.0382	0.0836	CbGbCtD
Leucovorin—ABCC2—Tamoxifen—pancreatic cancer	0.0308	0.0675	CbGbCtD
Leucovorin—ABCC4—Sunitinib—pancreatic cancer	0.029	0.0635	CbGbCtD
Leucovorin—ABCC3—Doxorubicin—pancreatic cancer	0.0285	0.0623	CbGbCtD
Leucovorin—ABCC2—Irinotecan—pancreatic cancer	0.0237	0.0518	CbGbCtD
Leucovorin—ABCC2—Docetaxel—pancreatic cancer	0.0174	0.038	CbGbCtD
Leucovorin—ABCC2—Sunitinib—pancreatic cancer	0.0173	0.0378	CbGbCtD
Leucovorin—ABCC2—Doxorubicin—pancreatic cancer	0.0129	0.0283	CbGbCtD
Leucovorin—ABCC3—bile duct—pancreatic cancer	0.0104	0.33	CbGeAlD
Leucovorin—ABCC2—bile duct—pancreatic cancer	0.00828	0.264	CbGeAlD
Leucovorin—ABCC2—bile—pancreatic cancer	0.00636	0.203	CbGeAlD
Leucovorin—ABCC3—gall bladder—pancreatic cancer	0.00221	0.0704	CbGeAlD
Leucovorin—TYMS—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.00175	0.0651	CbGpPWpGaD
Leucovorin—Pemetrexed—SLC29A1—pancreatic cancer	0.0016	0.387	CrCbGaD
Leucovorin—ABCC3—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.00145	0.0539	CbGpPWpGaD
Leucovorin—ABCC4—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.00136	0.0507	CbGpPWpGaD
Leucovorin—TYMS—Pyrimidine metabolism—TYMP—pancreatic cancer	0.00113	0.0422	CbGpPWpGaD
Leucovorin—TYMS—digestive system—pancreatic cancer	0.00106	0.0338	CbGeAlD
Leucovorin—TYMS—Paclitaxel—Docetaxel—pancreatic cancer	0.000941	0.451	CbGdCrCtD
Leucovorin—Raltitrexed—TYMS—pancreatic cancer	0.00094	0.227	CrCbGaD
Leucovorin—TYMS—Gefitinib—Erlotinib—pancreatic cancer	0.000903	0.433	CbGdCrCtD
Leucovorin—TYMS—Pyrimidine metabolism—DPYD—pancreatic cancer	0.000897	0.0334	CbGpPWpGaD
Leucovorin—TYMS—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.000877	0.0327	CbGpPWpGaD
Leucovorin—ABCC3—digestive system—pancreatic cancer	0.00087	0.0277	CbGeAlD
Leucovorin—ABCC4—pancreas—pancreatic cancer	0.000841	0.0268	CbGeAlD
Leucovorin—ABCC4—Ectoderm Differentiation—LY6E—pancreatic cancer	0.000824	0.0307	CbGpPWpGaD
Leucovorin—ABCC3—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.000726	0.027	CbGpPWpGaD
Leucovorin—ABCC4—digestive system—pancreatic cancer	0.000718	0.0229	CbGeAlD
Leucovorin—Pralatrexate—TYMS—pancreatic cancer	0.000713	0.172	CrCbGaD
Leucovorin—TYMS—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.000695	0.0259	CbGpPWpGaD
Leucovorin—ABCC2—digestive system—pancreatic cancer	0.000695	0.0221	CbGeAlD
Leucovorin—ABCC4—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.000682	0.0254	CbGpPWpGaD
Leucovorin—ABCC3—NRF2 pathway—FGF13—pancreatic cancer	0.000635	0.0237	CbGpPWpGaD
Leucovorin—ABCC4—NRF2 pathway—FGF13—pancreatic cancer	0.000597	0.0222	CbGpPWpGaD
Leucovorin—TYMS—E2F transcription factor network—RBBP8—pancreatic cancer	0.000581	0.0217	CbGpPWpGaD
Leucovorin—ABCC3—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.000576	0.0214	CbGpPWpGaD
Leucovorin—Pemetrexed—TYMS—pancreatic cancer	0.00057	0.138	CrCbGaD
Leucovorin—ABCC4—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.000541	0.0202	CbGpPWpGaD
Leucovorin—ABCC2—NRF2 pathway—FGF13—pancreatic cancer	0.000503	0.0188	CbGpPWpGaD
Leucovorin—TYMS—Nucleotide metabolism—TYMP—pancreatic cancer	0.000441	0.0164	CbGpPWpGaD
Leucovorin—TYMS—Nucleotide metabolism—DPYD—pancreatic cancer	0.000349	0.013	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	0.000339	0.0126	CbGpPWpGaD
Leucovorin—ABCC3—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.000328	0.0122	CbGpPWpGaD
Leucovorin—Methotrexate—TYMS—pancreatic cancer	0.000314	0.076	CrCbGaD
Leucovorin—ABCC4—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.000308	0.0115	CbGpPWpGaD
Leucovorin—TYMS—E2F mediated regulation of DNA replication—RB1—pancreatic cancer	0.000269	0.01	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.000246	0.00918	CbGpPWpGaD
Leucovorin—TYMS—Azacitidine—Gemcitabine—pancreatic cancer	0.000244	0.117	CbGdCrCtD
Leucovorin—TYMS—Cell Cycle—SYCP1—pancreatic cancer	0.000228	0.00848	CbGpPWpGaD
Leucovorin—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000227	0.00845	CbGpPWpGaD
Leucovorin—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000199	0.00252	CcSEcCtD
Leucovorin—Skin disorder—Sunitinib—pancreatic cancer	0.000197	0.0025	CcSEcCtD
Leucovorin—Erythema—Fluorouracil—pancreatic cancer	0.000196	0.00249	CcSEcCtD
Leucovorin—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000194	0.00246	CcSEcCtD
Leucovorin—Anorexia—Sunitinib—pancreatic cancer	0.000194	0.00245	CcSEcCtD
Leucovorin—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000192	0.00243	CcSEcCtD
Leucovorin—Ill-defined disorder—Irinotecan—pancreatic cancer	0.00019	0.00241	CcSEcCtD
Leucovorin—Neuropathy—Doxorubicin—pancreatic cancer	0.00019	0.00241	CcSEcCtD
Leucovorin—Urticaria—Tamoxifen—pancreatic cancer	0.000188	0.00239	CcSEcCtD
Leucovorin—Abdominal pain—Tamoxifen—pancreatic cancer	0.000187	0.00237	CcSEcCtD
Leucovorin—Body temperature increased—Erlotinib—pancreatic cancer	0.000185	0.00235	CcSEcCtD
Leucovorin—Abdominal pain—Erlotinib—pancreatic cancer	0.000185	0.00235	CcSEcCtD
Leucovorin—Ill-defined disorder—Gemcitabine—pancreatic cancer	0.000185	0.00235	CcSEcCtD
Leucovorin—Malaise—Irinotecan—pancreatic cancer	0.000185	0.00234	CcSEcCtD
Leucovorin—Syncope—Irinotecan—pancreatic cancer	0.000184	0.00233	CcSEcCtD
Leucovorin—Leukopenia—Irinotecan—pancreatic cancer	0.000183	0.00232	CcSEcCtD
Leucovorin—Dyspnoea—Sunitinib—pancreatic cancer	0.000181	0.00229	CcSEcCtD
Leucovorin—Loss of consciousness—Irinotecan—pancreatic cancer	0.00018	0.00228	CcSEcCtD
Leucovorin—Malaise—Gemcitabine—pancreatic cancer	0.00018	0.00228	CcSEcCtD
Leucovorin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.00018	0.0067	CbGpPWpGaD
Leucovorin—Dyspepsia—Sunitinib—pancreatic cancer	0.000179	0.00226	CcSEcCtD
Leucovorin—Leukopenia—Gemcitabine—pancreatic cancer	0.000179	0.00226	CcSEcCtD
Leucovorin—ABCC3—NRF2 pathway—NFE2L2—pancreatic cancer	0.000178	0.00663	CbGpPWpGaD
Leucovorin—Neuropathy peripheral—Docetaxel—pancreatic cancer	0.000178	0.00225	CcSEcCtD
Leucovorin—Stomatitis—Docetaxel—pancreatic cancer	0.000177	0.00224	CcSEcCtD
Leucovorin—Decreased appetite—Sunitinib—pancreatic cancer	0.000177	0.00224	CcSEcCtD
Leucovorin—Leukopenia—Fluorouracil—pancreatic cancer	0.000176	0.00223	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000175	0.00222	CcSEcCtD
Leucovorin—Fatigue—Sunitinib—pancreatic cancer	0.000175	0.00222	CcSEcCtD
Leucovorin—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000175	0.00221	CcSEcCtD
Leucovorin—Constipation—Sunitinib—pancreatic cancer	0.000174	0.0022	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	0.000173	0.00647	CbGpPWpGaD
Leucovorin—TYMS—E2F transcription factor network—PLAU—pancreatic cancer	0.000173	0.00645	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000173	0.00644	CbGpPWpGaD
Leucovorin—Discomfort—Irinotecan—pancreatic cancer	0.000172	0.00218	CcSEcCtD
Leucovorin—Renal failure acute—Epirubicin—pancreatic cancer	0.000172	0.00218	CcSEcCtD
Leucovorin—TYMS—Circadian rythm related genes—AHR—pancreatic cancer	0.000171	0.00637	CbGpPWpGaD
Leucovorin—Asthenia—Tamoxifen—pancreatic cancer	0.00017	0.00216	CcSEcCtD
Leucovorin—Convulsion—Fluorouracil—pancreatic cancer	0.00017	0.00215	CcSEcCtD
Leucovorin—ABCC3—NRF2 pathway—TGFA—pancreatic cancer	0.00017	0.00633	CbGpPWpGaD
Leucovorin—Confusional state—Irinotecan—pancreatic cancer	0.000169	0.00214	CcSEcCtD
Leucovorin—Asthenia—Erlotinib—pancreatic cancer	0.000168	0.00213	CcSEcCtD
Leucovorin—Discomfort—Gemcitabine—pancreatic cancer	0.000168	0.00213	CcSEcCtD
Leucovorin—Pruritus—Tamoxifen—pancreatic cancer	0.000168	0.00213	CcSEcCtD
Leucovorin—ABCC4—NRF2 pathway—NFE2L2—pancreatic cancer	0.000167	0.00624	CbGpPWpGaD
Leucovorin—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000167	0.00212	CcSEcCtD
Leucovorin—Renal impairment—Epirubicin—pancreatic cancer	0.000167	0.00211	CcSEcCtD
Leucovorin—Infection—Irinotecan—pancreatic cancer	0.000166	0.00211	CcSEcCtD
Leucovorin—ABCC3—NRF2 pathway—SLC2A2—pancreatic cancer	0.000166	0.00619	CbGpPWpGaD
Leucovorin—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000166	0.0021	CcSEcCtD
Leucovorin—Pruritus—Erlotinib—pancreatic cancer	0.000166	0.0021	CcSEcCtD
Leucovorin—Discomfort—Fluorouracil—pancreatic cancer	0.000165	0.00209	CcSEcCtD
Leucovorin—Shock—Irinotecan—pancreatic cancer	0.000165	0.00208	CcSEcCtD
Leucovorin—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.000164	0.00208	CcSEcCtD
Leucovorin—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000164	0.00207	CcSEcCtD
Leucovorin—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000163	0.00206	CcSEcCtD
Leucovorin—ABCC4—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000162	0.00606	CbGpPWpGaD
Leucovorin—Diarrhoea—Tamoxifen—pancreatic cancer	0.000162	0.00206	CcSEcCtD
Leucovorin—Lethargy—Epirubicin—pancreatic cancer	0.000162	0.00205	CcSEcCtD
Leucovorin—Infection—Gemcitabine—pancreatic cancer	0.000162	0.00205	CcSEcCtD
Leucovorin—Confusional state—Fluorouracil—pancreatic cancer	0.000162	0.00205	CcSEcCtD
Leucovorin—Abdominal pain—Sunitinib—pancreatic cancer	0.000161	0.00203	CcSEcCtD
Leucovorin—Body temperature increased—Sunitinib—pancreatic cancer	0.000161	0.00203	CcSEcCtD
Leucovorin—Diarrhoea—Erlotinib—pancreatic cancer	0.000161	0.00203	CcSEcCtD
Leucovorin—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00016	0.00203	CcSEcCtD
Leucovorin—ABCC4—NRF2 pathway—TGFA—pancreatic cancer	0.00016	0.00595	CbGpPWpGaD
Leucovorin—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00016	0.00202	CcSEcCtD
Leucovorin—Anorexia—Irinotecan—pancreatic cancer	0.000159	0.00202	CcSEcCtD
Leucovorin—Infection—Fluorouracil—pancreatic cancer	0.000159	0.00202	CcSEcCtD
Leucovorin—Renal failure acute—Doxorubicin—pancreatic cancer	0.000159	0.00201	CcSEcCtD
Leucovorin—Skin disorder—Gemcitabine—pancreatic cancer	0.000158	0.00201	CcSEcCtD
Leucovorin—ABCC4—Ectoderm Differentiation—SHH—pancreatic cancer	0.000157	0.00585	CbGpPWpGaD
Leucovorin—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000157	0.00199	CcSEcCtD
Leucovorin—Dizziness—Tamoxifen—pancreatic cancer	0.000157	0.00199	CcSEcCtD
Leucovorin—ABCC4—NRF2 pathway—SLC2A2—pancreatic cancer	0.000156	0.00582	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	0.000156	0.0058	CbGpPWpGaD
Leucovorin—Anorexia—Gemcitabine—pancreatic cancer	0.000155	0.00197	CcSEcCtD
Leucovorin—Dizziness—Erlotinib—pancreatic cancer	0.000155	0.00197	CcSEcCtD
Leucovorin—Renal impairment—Doxorubicin—pancreatic cancer	0.000154	0.00195	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	0.000154	0.00573	CbGpPWpGaD
Leucovorin—Anorexia—Fluorouracil—pancreatic cancer	0.000153	0.00193	CcSEcCtD
Leucovorin—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.000152	0.00192	CcSEcCtD
Leucovorin—Vomiting—Tamoxifen—pancreatic cancer	0.000151	0.00191	CcSEcCtD
Leucovorin—Lethargy—Doxorubicin—pancreatic cancer	0.00015	0.0019	CcSEcCtD
Leucovorin—Hypersensitivity—Sunitinib—pancreatic cancer	0.00015	0.0019	CcSEcCtD
Leucovorin—Rash—Tamoxifen—pancreatic cancer	0.00015	0.00189	CcSEcCtD
Leucovorin—Dermatitis—Tamoxifen—pancreatic cancer	0.000149	0.00189	CcSEcCtD
Leucovorin—Vomiting—Erlotinib—pancreatic cancer	0.000149	0.00189	CcSEcCtD
Leucovorin—Dyspnoea—Irinotecan—pancreatic cancer	0.000149	0.00189	CcSEcCtD
Leucovorin—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000149	0.00188	CcSEcCtD
Leucovorin—Rash—Erlotinib—pancreatic cancer	0.000148	0.00187	CcSEcCtD
Leucovorin—Dermatitis—Erlotinib—pancreatic cancer	0.000148	0.00187	CcSEcCtD
Leucovorin—Dyspepsia—Irinotecan—pancreatic cancer	0.000147	0.00187	CcSEcCtD
Leucovorin—Chills—Docetaxel—pancreatic cancer	0.000146	0.00185	CcSEcCtD
Leucovorin—Asthenia—Sunitinib—pancreatic cancer	0.000146	0.00185	CcSEcCtD
Leucovorin—Decreased appetite—Irinotecan—pancreatic cancer	0.000145	0.00184	CcSEcCtD
Leucovorin—Dyspnoea—Gemcitabine—pancreatic cancer	0.000145	0.00184	CcSEcCtD
Leucovorin—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000145	0.00184	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000144	0.00183	CcSEcCtD
Leucovorin—Fatigue—Irinotecan—pancreatic cancer	0.000144	0.00183	CcSEcCtD
Leucovorin—Alopecia—Docetaxel—pancreatic cancer	0.000144	0.00182	CcSEcCtD
Leucovorin—Pruritus—Sunitinib—pancreatic cancer	0.000144	0.00182	CcSEcCtD
Leucovorin—Constipation—Irinotecan—pancreatic cancer	0.000143	0.00181	CcSEcCtD
Leucovorin—Dyspnoea—Fluorouracil—pancreatic cancer	0.000143	0.00181	CcSEcCtD
Leucovorin—TYMS—E2F transcription factor network—RB1—pancreatic cancer	0.000142	0.0053	CbGpPWpGaD
Leucovorin—Erythema—Docetaxel—pancreatic cancer	0.000142	0.00179	CcSEcCtD
Leucovorin—Decreased appetite—Gemcitabine—pancreatic cancer	0.000142	0.00179	CcSEcCtD
Leucovorin—ABCC2—NRF2 pathway—NFE2L2—pancreatic cancer	0.000141	0.00526	CbGpPWpGaD
Leucovorin—Dyspepsia—Fluorouracil—pancreatic cancer	0.000141	0.00179	CcSEcCtD
Leucovorin—ABCC3—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000141	0.00525	CbGpPWpGaD
Leucovorin—Nausea—Tamoxifen—pancreatic cancer	0.000141	0.00178	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000141	0.00178	CcSEcCtD
Leucovorin—Fatigue—Gemcitabine—pancreatic cancer	0.000141	0.00178	CcSEcCtD
Leucovorin—Constipation—Gemcitabine—pancreatic cancer	0.000139	0.00177	CcSEcCtD
Leucovorin—Nausea—Erlotinib—pancreatic cancer	0.000139	0.00177	CcSEcCtD
Leucovorin—Decreased appetite—Fluorouracil—pancreatic cancer	0.000139	0.00176	CcSEcCtD
Leucovorin—Diarrhoea—Sunitinib—pancreatic cancer	0.000139	0.00176	CcSEcCtD
Leucovorin—Dysgeusia—Docetaxel—pancreatic cancer	0.000139	0.00176	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000138	0.00175	CcSEcCtD
Leucovorin—Feeling abnormal—Irinotecan—pancreatic cancer	0.000138	0.00175	CcSEcCtD
Leucovorin—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000138	0.00174	CcSEcCtD
Leucovorin—ABCC2—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000137	0.00511	CbGpPWpGaD
Leucovorin—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000137	0.00173	CcSEcCtD
Leucovorin—ABCC2—NRF2 pathway—TGFA—pancreatic cancer	0.000135	0.00502	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	0.000134	0.00501	CbGpPWpGaD
Leucovorin—Dizziness—Sunitinib—pancreatic cancer	0.000134	0.0017	CcSEcCtD
Leucovorin—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000134	0.0017	CcSEcCtD
Leucovorin—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000134	0.0017	CcSEcCtD
Leucovorin—ABCC4—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000132	0.00494	CbGpPWpGaD
Leucovorin—Abdominal pain—Irinotecan—pancreatic cancer	0.000132	0.00168	CcSEcCtD
Leucovorin—Body temperature increased—Irinotecan—pancreatic cancer	0.000132	0.00168	CcSEcCtD
Leucovorin—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000132	0.00167	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	0.000132	0.00492	CbGpPWpGaD
Leucovorin—ABCC2—NRF2 pathway—SLC2A2—pancreatic cancer	0.000132	0.00491	CbGpPWpGaD
Leucovorin—TYMS—Fluoropyrimidine Activity—TP53—pancreatic cancer	0.000131	0.0049	CbGpPWpGaD
Leucovorin—Vomiting—Sunitinib—pancreatic cancer	0.000129	0.00164	CcSEcCtD
Leucovorin—TYMS—Circadian rythm related genes—EZH2—pancreatic cancer	0.000129	0.00481	CbGpPWpGaD
Leucovorin—Body temperature increased—Gemcitabine—pancreatic cancer	0.000129	0.00163	CcSEcCtD
Leucovorin—Rash—Sunitinib—pancreatic cancer	0.000128	0.00162	CcSEcCtD
Leucovorin—Dermatitis—Sunitinib—pancreatic cancer	0.000128	0.00162	CcSEcCtD
Leucovorin—ABCC3—NRF2 pathway—HSPA1A—pancreatic cancer	0.000128	0.00476	CbGpPWpGaD
Leucovorin—Urticaria—Fluorouracil—pancreatic cancer	0.000127	0.00161	CcSEcCtD
Leucovorin—Syncope—Docetaxel—pancreatic cancer	0.000127	0.00161	CcSEcCtD
Leucovorin—Leukopenia—Docetaxel—pancreatic cancer	0.000127	0.00161	CcSEcCtD
Leucovorin—Body temperature increased—Fluorouracil—pancreatic cancer	0.000127	0.0016	CcSEcCtD
Leucovorin—TYMS—E2F transcription factor network—CDKN2A—pancreatic cancer	0.000125	0.00466	CbGpPWpGaD
Leucovorin—Loss of consciousness—Docetaxel—pancreatic cancer	0.000125	0.00158	CcSEcCtD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—RB1—pancreatic cancer	0.000124	0.00461	CbGpPWpGaD
Leucovorin—Hypersensitivity—Irinotecan—pancreatic cancer	0.000123	0.00156	CcSEcCtD
Leucovorin—Convulsion—Docetaxel—pancreatic cancer	0.000123	0.00156	CcSEcCtD
Leucovorin—Nausea—Sunitinib—pancreatic cancer	0.000121	0.00153	CcSEcCtD
Leucovorin—ABCC4—NRF2 pathway—HSPA1A—pancreatic cancer	0.00012	0.00448	CbGpPWpGaD
Leucovorin—Asthenia—Irinotecan—pancreatic cancer	0.00012	0.00152	CcSEcCtD
Leucovorin—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.00012	0.00152	CcSEcCtD
Leucovorin—Stomatitis—Epirubicin—pancreatic cancer	0.000119	0.00151	CcSEcCtD
Leucovorin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000118	0.0015	CcSEcCtD
Leucovorin—Asthenia—Gemcitabine—pancreatic cancer	0.000117	0.00148	CcSEcCtD
Leucovorin—Confusional state—Docetaxel—pancreatic cancer	0.000117	0.00148	CcSEcCtD
Leucovorin—TYMS—Cell Cycle—RBBP8—pancreatic cancer	0.000117	0.00434	CbGpPWpGaD
Leucovorin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000116	0.00146	CcSEcCtD
Leucovorin—Pruritus—Gemcitabine—pancreatic cancer	0.000115	0.00146	CcSEcCtD
Leucovorin—Infection—Docetaxel—pancreatic cancer	0.000115	0.00146	CcSEcCtD
Leucovorin—Diarrhoea—Irinotecan—pancreatic cancer	0.000114	0.00145	CcSEcCtD
Leucovorin—Shock—Docetaxel—pancreatic cancer	0.000114	0.00144	CcSEcCtD
Leucovorin—Pruritus—Fluorouracil—pancreatic cancer	0.000113	0.00144	CcSEcCtD
Leucovorin—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000113	0.00143	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	0.000113	0.00421	CbGpPWpGaD
Leucovorin—Skin disorder—Docetaxel—pancreatic cancer	0.000112	0.00142	CcSEcCtD
Leucovorin—ABCC2—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000112	0.00416	CbGpPWpGaD
Leucovorin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000112	0.00141	CcSEcCtD
Leucovorin—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000111	0.00141	CcSEcCtD
Leucovorin—Dizziness—Irinotecan—pancreatic cancer	0.000111	0.0014	CcSEcCtD
Leucovorin—Stomatitis—Doxorubicin—pancreatic cancer	0.00011	0.0014	CcSEcCtD
Leucovorin—Anorexia—Docetaxel—pancreatic cancer	0.00011	0.0014	CcSEcCtD
Leucovorin—ABCC4—Platelet degranulation—EGF—pancreatic cancer	0.00011	0.00411	CbGpPWpGaD
Leucovorin—Diarrhoea—Fluorouracil—pancreatic cancer	0.00011	0.00139	CcSEcCtD
Leucovorin—ABCC3—Fluoropyrimidine Activity—TP53—pancreatic cancer	0.000109	0.00405	CbGpPWpGaD
Leucovorin—Vomiting—Irinotecan—pancreatic cancer	0.000106	0.00135	CcSEcCtD
Leucovorin—Dizziness—Fluorouracil—pancreatic cancer	0.000106	0.00134	CcSEcCtD
Leucovorin—Rash—Irinotecan—pancreatic cancer	0.000105	0.00134	CcSEcCtD
Leucovorin—Dermatitis—Irinotecan—pancreatic cancer	0.000105	0.00133	CcSEcCtD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—EGF—pancreatic cancer	0.000105	0.00391	CbGpPWpGaD
Leucovorin—Vomiting—Gemcitabine—pancreatic cancer	0.000104	0.00131	CcSEcCtD
Leucovorin—TYMS—G1/S Transition—RB1—pancreatic cancer	0.000103	0.00385	CbGpPWpGaD
Leucovorin—Dyspnoea—Docetaxel—pancreatic cancer	0.000103	0.00131	CcSEcCtD
Leucovorin—Rash—Gemcitabine—pancreatic cancer	0.000103	0.0013	CcSEcCtD
Leucovorin—Dermatitis—Gemcitabine—pancreatic cancer	0.000103	0.0013	CcSEcCtD
Leucovorin—ABCC4—Fluoropyrimidine Activity—TP53—pancreatic cancer	0.000102	0.00381	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	0.000102	0.00381	CbGpPWpGaD
Leucovorin—Vomiting—Fluorouracil—pancreatic cancer	0.000102	0.00129	CcSEcCtD
Leucovorin—Dyspepsia—Docetaxel—pancreatic cancer	0.000102	0.00129	CcSEcCtD
Leucovorin—TYMS—Cell Cycle, Mitotic—PPP2R5B—pancreatic cancer	0.000101	0.00378	CbGpPWpGaD
Leucovorin—ABCC2—NRF2 pathway—HSPA1A—pancreatic cancer	0.000101	0.00378	CbGpPWpGaD
Leucovorin—Rash—Fluorouracil—pancreatic cancer	0.000101	0.00128	CcSEcCtD
Leucovorin—Dermatitis—Fluorouracil—pancreatic cancer	0.000101	0.00128	CcSEcCtD
Leucovorin—Decreased appetite—Docetaxel—pancreatic cancer	0.000101	0.00127	CcSEcCtD
Leucovorin—ABCC4—Ectoderm Differentiation—SMAD4—pancreatic cancer	9.99e-05	0.00372	CbGpPWpGaD
Leucovorin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	9.98e-05	0.00126	CcSEcCtD
Leucovorin—Fatigue—Docetaxel—pancreatic cancer	9.97e-05	0.00126	CcSEcCtD
Leucovorin—Nausea—Irinotecan—pancreatic cancer	9.94e-05	0.00126	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	9.9e-05	0.00369	CbGpPWpGaD
Leucovorin—Constipation—Docetaxel—pancreatic cancer	9.89e-05	0.00125	CcSEcCtD
Leucovorin—Chills—Epirubicin—pancreatic cancer	9.85e-05	0.00125	CcSEcCtD
Leucovorin—Alopecia—Epirubicin—pancreatic cancer	9.7e-05	0.00123	CcSEcCtD
Leucovorin—Nausea—Gemcitabine—pancreatic cancer	9.68e-05	0.00123	CcSEcCtD
Leucovorin—Erythema—Epirubicin—pancreatic cancer	9.56e-05	0.00121	CcSEcCtD
Leucovorin—Feeling abnormal—Docetaxel—pancreatic cancer	9.53e-05	0.00121	CcSEcCtD
Leucovorin—Nausea—Fluorouracil—pancreatic cancer	9.52e-05	0.00121	CcSEcCtD
Leucovorin—Gastrointestinal pain—Docetaxel—pancreatic cancer	9.46e-05	0.0012	CcSEcCtD
Leucovorin—Dysgeusia—Epirubicin—pancreatic cancer	9.36e-05	0.00119	CcSEcCtD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—CCND1—pancreatic cancer	9.19e-05	0.00342	CbGpPWpGaD
Leucovorin—Abdominal pain—Docetaxel—pancreatic cancer	9.14e-05	0.00116	CcSEcCtD
Leucovorin—Body temperature increased—Docetaxel—pancreatic cancer	9.14e-05	0.00116	CcSEcCtD
Leucovorin—Chills—Doxorubicin—pancreatic cancer	9.12e-05	0.00115	CcSEcCtD
Leucovorin—TYMS—Cell Cycle—PPP2R5B—pancreatic cancer	9.06e-05	0.00338	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—FOXM1—pancreatic cancer	9.03e-05	0.00337	CbGpPWpGaD
Leucovorin—Alopecia—Doxorubicin—pancreatic cancer	8.98e-05	0.00114	CcSEcCtD
Leucovorin—Ill-defined disorder—Epirubicin—pancreatic cancer	8.87e-05	0.00112	CcSEcCtD
Leucovorin—Erythema—Doxorubicin—pancreatic cancer	8.84e-05	0.00112	CcSEcCtD
Leucovorin—TYMS—Mitotic G1-G1/S phases—RB1—pancreatic cancer	8.7e-05	0.00324	CbGpPWpGaD
Leucovorin—Dysgeusia—Doxorubicin—pancreatic cancer	8.66e-05	0.0011	CcSEcCtD
Leucovorin—Malaise—Epirubicin—pancreatic cancer	8.62e-05	0.00109	CcSEcCtD
Leucovorin—Syncope—Epirubicin—pancreatic cancer	8.57e-05	0.00109	CcSEcCtD
Leucovorin—Leukopenia—Epirubicin—pancreatic cancer	8.56e-05	0.00108	CcSEcCtD
Leucovorin—Hypersensitivity—Docetaxel—pancreatic cancer	8.52e-05	0.00108	CcSEcCtD
Leucovorin—TYMS—E2F transcription factor network—MYC—pancreatic cancer	8.48e-05	0.00316	CbGpPWpGaD
Leucovorin—Loss of consciousness—Epirubicin—pancreatic cancer	8.4e-05	0.00106	CcSEcCtD
Leucovorin—Asthenia—Docetaxel—pancreatic cancer	8.3e-05	0.00105	CcSEcCtD
Leucovorin—Convulsion—Epirubicin—pancreatic cancer	8.28e-05	0.00105	CcSEcCtD
Leucovorin—Ill-defined disorder—Doxorubicin—pancreatic cancer	8.21e-05	0.00104	CcSEcCtD
Leucovorin—Pruritus—Docetaxel—pancreatic cancer	8.18e-05	0.00104	CcSEcCtD
Leucovorin—TYMS—Cell Cycle—FOXM1—pancreatic cancer	8.08e-05	0.00301	CbGpPWpGaD
Leucovorin—Discomfort—Epirubicin—pancreatic cancer	8.04e-05	0.00102	CcSEcCtD
Leucovorin—Malaise—Doxorubicin—pancreatic cancer	7.98e-05	0.00101	CcSEcCtD
Leucovorin—Syncope—Doxorubicin—pancreatic cancer	7.93e-05	0.001	CcSEcCtD
Leucovorin—Leukopenia—Doxorubicin—pancreatic cancer	7.92e-05	0.001	CcSEcCtD
Leucovorin—ABCC4—Hemostasis—IFNA5—pancreatic cancer	7.91e-05	0.00295	CbGpPWpGaD
Leucovorin—Diarrhoea—Docetaxel—pancreatic cancer	7.91e-05	0.001	CcSEcCtD
Leucovorin—Confusional state—Epirubicin—pancreatic cancer	7.87e-05	0.000996	CcSEcCtD
Leucovorin—Anaphylactic shock—Epirubicin—pancreatic cancer	7.8e-05	0.000988	CcSEcCtD
Leucovorin—Loss of consciousness—Doxorubicin—pancreatic cancer	7.77e-05	0.000985	CcSEcCtD
Leucovorin—Infection—Epirubicin—pancreatic cancer	7.75e-05	0.000982	CcSEcCtD
Leucovorin—Shock—Epirubicin—pancreatic cancer	7.67e-05	0.000972	CcSEcCtD
Leucovorin—Convulsion—Doxorubicin—pancreatic cancer	7.66e-05	0.000971	CcSEcCtD
Leucovorin—TYMS—Mitotic G1-G1/S phases—CDKN2A—pancreatic cancer	7.65e-05	0.00285	CbGpPWpGaD
Leucovorin—Dizziness—Docetaxel—pancreatic cancer	7.65e-05	0.000969	CcSEcCtD
Leucovorin—Thrombocytopenia—Epirubicin—pancreatic cancer	7.64e-05	0.000967	CcSEcCtD
Leucovorin—Skin disorder—Epirubicin—pancreatic cancer	7.58e-05	0.00096	CcSEcCtD
Leucovorin—ABCC4—Hemostasis—PPP2R5B—pancreatic cancer	7.47e-05	0.00279	CbGpPWpGaD
Leucovorin—Discomfort—Doxorubicin—pancreatic cancer	7.44e-05	0.000942	CcSEcCtD
Leucovorin—Anorexia—Epirubicin—pancreatic cancer	7.44e-05	0.000942	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	7.37e-05	0.00275	CbGpPWpGaD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—MYC—pancreatic cancer	7.37e-05	0.00275	CbGpPWpGaD
Leucovorin—Vomiting—Docetaxel—pancreatic cancer	7.35e-05	0.000931	CcSEcCtD
Leucovorin—Rash—Docetaxel—pancreatic cancer	7.29e-05	0.000924	CcSEcCtD
Leucovorin—Dermatitis—Docetaxel—pancreatic cancer	7.29e-05	0.000923	CcSEcCtD
Leucovorin—Confusional state—Doxorubicin—pancreatic cancer	7.28e-05	0.000922	CcSEcCtD
Leucovorin—Anaphylactic shock—Doxorubicin—pancreatic cancer	7.22e-05	0.000914	CcSEcCtD
Leucovorin—Infection—Doxorubicin—pancreatic cancer	7.17e-05	0.000908	CcSEcCtD
Leucovorin—Shock—Doxorubicin—pancreatic cancer	7.1e-05	0.000899	CcSEcCtD
Leucovorin—Thrombocytopenia—Doxorubicin—pancreatic cancer	7.07e-05	0.000895	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	7.06e-05	0.00263	CbGpPWpGaD
Leucovorin—Skin disorder—Doxorubicin—pancreatic cancer	7.01e-05	0.000888	CcSEcCtD
Leucovorin—Dyspnoea—Epirubicin—pancreatic cancer	6.95e-05	0.000881	CcSEcCtD
Leucovorin—Anorexia—Doxorubicin—pancreatic cancer	6.88e-05	0.000871	CcSEcCtD
Leucovorin—Nausea—Docetaxel—pancreatic cancer	6.87e-05	0.00087	CcSEcCtD
Leucovorin—Dyspepsia—Epirubicin—pancreatic cancer	6.87e-05	0.00087	CcSEcCtD
Leucovorin—Decreased appetite—Epirubicin—pancreatic cancer	6.78e-05	0.000859	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	6.73e-05	0.000853	CcSEcCtD
Leucovorin—Fatigue—Epirubicin—pancreatic cancer	6.73e-05	0.000852	CcSEcCtD
Leucovorin—Constipation—Epirubicin—pancreatic cancer	6.67e-05	0.000845	CcSEcCtD
Leucovorin—ABCC4—Platelet degranulation—VEGFA—pancreatic cancer	6.66e-05	0.00248	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—PPARG—pancreatic cancer	6.61e-05	0.00246	CbGpPWpGaD
Leucovorin—TYMS—Mitotic G1-G1/S phases—CCND1—pancreatic cancer	6.46e-05	0.00241	CbGpPWpGaD
Leucovorin—Dyspnoea—Doxorubicin—pancreatic cancer	6.44e-05	0.000815	CcSEcCtD
Leucovorin—Feeling abnormal—Epirubicin—pancreatic cancer	6.43e-05	0.000814	CcSEcCtD
Leucovorin—Gastrointestinal pain—Epirubicin—pancreatic cancer	6.38e-05	0.000808	CcSEcCtD
Leucovorin—Dyspepsia—Doxorubicin—pancreatic cancer	6.35e-05	0.000805	CcSEcCtD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—pancreatic cancer	6.35e-05	0.00237	CbGpPWpGaD
Leucovorin—Decreased appetite—Doxorubicin—pancreatic cancer	6.27e-05	0.000795	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	6.23e-05	0.000789	CcSEcCtD
Leucovorin—Fatigue—Doxorubicin—pancreatic cancer	6.22e-05	0.000788	CcSEcCtD
Leucovorin—Urticaria—Epirubicin—pancreatic cancer	6.2e-05	0.000785	CcSEcCtD
Leucovorin—Constipation—Doxorubicin—pancreatic cancer	6.17e-05	0.000782	CcSEcCtD
Leucovorin—Abdominal pain—Epirubicin—pancreatic cancer	6.17e-05	0.000781	CcSEcCtD
Leucovorin—Body temperature increased—Epirubicin—pancreatic cancer	6.17e-05	0.000781	CcSEcCtD
Leucovorin—TYMS—G1/S Transition—MYC—pancreatic cancer	6.15e-05	0.00229	CbGpPWpGaD
Leucovorin—ABCC4—Platelet degranulation—TGFB1—pancreatic cancer	6.12e-05	0.00228	CbGpPWpGaD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—TP53—pancreatic cancer	6.05e-05	0.00226	CbGpPWpGaD
Leucovorin—Feeling abnormal—Doxorubicin—pancreatic cancer	5.95e-05	0.000753	CcSEcCtD
Leucovorin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	5.9e-05	0.000748	CcSEcCtD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—pancreatic cancer	5.83e-05	0.00217	CbGpPWpGaD
Leucovorin—Hypersensitivity—Epirubicin—pancreatic cancer	5.75e-05	0.000728	CcSEcCtD
Leucovorin—Urticaria—Doxorubicin—pancreatic cancer	5.73e-05	0.000726	CcSEcCtD
Leucovorin—Abdominal pain—Doxorubicin—pancreatic cancer	5.71e-05	0.000723	CcSEcCtD
Leucovorin—Body temperature increased—Doxorubicin—pancreatic cancer	5.71e-05	0.000723	CcSEcCtD
Leucovorin—Asthenia—Epirubicin—pancreatic cancer	5.6e-05	0.000709	CcSEcCtD
Leucovorin—Pruritus—Epirubicin—pancreatic cancer	5.52e-05	0.000699	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	5.42e-05	0.00202	CbGpPWpGaD
Leucovorin—Diarrhoea—Epirubicin—pancreatic cancer	5.34e-05	0.000676	CcSEcCtD
Leucovorin—ABCC3—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	5.32e-05	0.00198	CbGpPWpGaD
Leucovorin—Hypersensitivity—Doxorubicin—pancreatic cancer	5.32e-05	0.000674	CcSEcCtD
Leucovorin—TYMS—Metabolism—PRSS1—pancreatic cancer	5.28e-05	0.00197	CbGpPWpGaD
Leucovorin—TYMS—Mitotic G1-G1/S phases—MYC—pancreatic cancer	5.18e-05	0.00193	CbGpPWpGaD
Leucovorin—Asthenia—Doxorubicin—pancreatic cancer	5.18e-05	0.000656	CcSEcCtD
Leucovorin—Dizziness—Epirubicin—pancreatic cancer	5.16e-05	0.000653	CcSEcCtD
Leucovorin—Pruritus—Doxorubicin—pancreatic cancer	5.11e-05	0.000647	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	5.03e-05	0.00187	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	5e-05	0.00187	CbGpPWpGaD
Leucovorin—Vomiting—Epirubicin—pancreatic cancer	4.96e-05	0.000628	CcSEcCtD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—pancreatic cancer	4.94e-05	0.00184	CbGpPWpGaD
Leucovorin—Diarrhoea—Doxorubicin—pancreatic cancer	4.94e-05	0.000626	CcSEcCtD
Leucovorin—Rash—Epirubicin—pancreatic cancer	4.92e-05	0.000623	CcSEcCtD
Leucovorin—Dermatitis—Epirubicin—pancreatic cancer	4.91e-05	0.000622	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	4.9e-05	0.00182	CbGpPWpGaD
Leucovorin—ABCC4—Ectoderm Differentiation—CTNNB1—pancreatic cancer	4.89e-05	0.00182	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—EGF—pancreatic cancer	4.89e-05	0.00182	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	4.85e-05	0.00181	CbGpPWpGaD
Leucovorin—Dizziness—Doxorubicin—pancreatic cancer	4.77e-05	0.000605	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	4.73e-05	0.00176	CbGpPWpGaD
Leucovorin—Nausea—Epirubicin—pancreatic cancer	4.63e-05	0.000587	CcSEcCtD
Leucovorin—Vomiting—Doxorubicin—pancreatic cancer	4.59e-05	0.000581	CcSEcCtD
Leucovorin—TYMS—Metabolism—ARG2—pancreatic cancer	4.58e-05	0.00171	CbGpPWpGaD
Leucovorin—Rash—Doxorubicin—pancreatic cancer	4.55e-05	0.000576	CcSEcCtD
Leucovorin—Dermatitis—Doxorubicin—pancreatic cancer	4.55e-05	0.000576	CcSEcCtD
Leucovorin—TYMS—Circadian rythm related genes—PTEN—pancreatic cancer	4.54e-05	0.00169	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—CD44—pancreatic cancer	4.48e-05	0.00167	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—BRCA2—pancreatic cancer	4.43e-05	0.00165	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	4.38e-05	0.00163	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PRSS1—pancreatic cancer	4.37e-05	0.00163	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	4.35e-05	0.00162	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—IFNA1—pancreatic cancer	4.34e-05	0.00162	CbGpPWpGaD
Leucovorin—Nausea—Doxorubicin—pancreatic cancer	4.29e-05	0.000543	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	4.27e-05	0.00159	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.22e-05	0.00157	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—IFNA2—pancreatic cancer	4.04e-05	0.0015	CbGpPWpGaD
Leucovorin—ABCC3—NRF2 pathway—TGFB1—pancreatic cancer	4.02e-05	0.0015	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—TYMP—pancreatic cancer	4e-05	0.00149	CbGpPWpGaD
Leucovorin—ABCC4—Ectoderm Differentiation—MYC—pancreatic cancer	3.96e-05	0.00148	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	3.93e-05	0.00146	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	3.92e-05	0.00146	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	3.84e-05	0.00143	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—ARG2—pancreatic cancer	3.79e-05	0.00141	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	3.79e-05	0.00141	CbGpPWpGaD
Leucovorin—ABCC4—NRF2 pathway—TGFB1—pancreatic cancer	3.78e-05	0.00141	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—TERT—pancreatic cancer	3.67e-05	0.00137	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	3.66e-05	0.00136	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	3.63e-05	0.00135	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	3.33e-05	0.00124	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—TYMP—pancreatic cancer	3.31e-05	0.00123	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—GLP1R—pancreatic cancer	3.23e-05	0.0012	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	3.23e-05	0.0012	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—RB1—pancreatic cancer	3.19e-05	0.00119	CbGpPWpGaD
Leucovorin—ABCC2—NRF2 pathway—TGFB1—pancreatic cancer	3.19e-05	0.00119	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—DPYD—pancreatic cancer	3.17e-05	0.00118	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—TP53—pancreatic cancer	3.1e-05	0.00115	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	3.04e-05	0.00113	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—SLC2A2—pancreatic cancer	3.01e-05	0.00112	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	2.96e-05	0.0011	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PLAU—pancreatic cancer	2.86e-05	0.00107	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—RB1—pancreatic cancer	2.85e-05	0.00106	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	2.81e-05	0.00105	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.73e-05	0.00102	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	2.72e-05	0.00102	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	2.71e-05	0.00101	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—GLP1R—pancreatic cancer	2.67e-05	0.000995	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—DPYD—pancreatic cancer	2.63e-05	0.000979	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PIK3CG—pancreatic cancer	2.55e-05	0.00095	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—EGF—pancreatic cancer	2.52e-05	0.000939	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CDKN2A—pancreatic cancer	2.51e-05	0.000935	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—SLC2A2—pancreatic cancer	2.49e-05	0.000929	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.47e-05	0.000919	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.38e-05	0.000887	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—CCND1—pancreatic cancer	2.37e-05	0.000883	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—CD44—pancreatic cancer	2.33e-05	0.000869	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	2.31e-05	0.000861	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PIK3CD—pancreatic cancer	2.24e-05	0.000835	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—GCG—pancreatic cancer	2.24e-05	0.000833	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.17e-05	0.000808	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CCND1—pancreatic cancer	2.12e-05	0.00079	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—STK11—pancreatic cancer	2.1e-05	0.000784	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PIK3CB—pancreatic cancer	1.95e-05	0.000728	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CD44—pancreatic cancer	1.93e-05	0.00072	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—MYC—pancreatic cancer	1.9e-05	0.000709	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.89e-05	0.000705	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	1.89e-05	0.000703	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.87e-05	0.000698	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—GCG—pancreatic cancer	1.85e-05	0.00069	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—STK11—pancreatic cancer	1.74e-05	0.000649	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—MYC—pancreatic cancer	1.7e-05	0.000634	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.63e-05	0.000609	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—SRC—pancreatic cancer	1.56e-05	0.000583	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—VEGFA—pancreatic cancer	1.52e-05	0.000568	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—NRAS—pancreatic cancer	1.51e-05	0.000561	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—TYMS—pancreatic cancer	1.5e-05	0.000558	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—APOE—pancreatic cancer	1.47e-05	0.000548	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—TGFB1—pancreatic cancer	1.4e-05	0.000521	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—TP53—pancreatic cancer	1.4e-05	0.00052	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PIK3CG—pancreatic cancer	1.33e-05	0.000495	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—KRAS—pancreatic cancer	1.3e-05	0.000483	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PPARG—pancreatic cancer	1.28e-05	0.000477	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—APOE—pancreatic cancer	1.22e-05	0.000454	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PIK3CA—pancreatic cancer	1.19e-05	0.000444	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PIK3CD—pancreatic cancer	1.17e-05	0.000435	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.15e-05	0.00043	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—TP53—pancreatic cancer	1.15e-05	0.000429	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—HRAS—pancreatic cancer	1.1e-05	0.00041	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PIK3CG—pancreatic cancer	1.1e-05	0.000409	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PPARG—pancreatic cancer	1.06e-05	0.000395	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PIK3CB—pancreatic cancer	1.02e-05	0.000379	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PTGS2—pancreatic cancer	1.01e-05	0.000376	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—AKT1—pancreatic cancer	9.72e-06	0.000362	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PIK3CD—pancreatic cancer	9.66e-06	0.00036	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PTEN—pancreatic cancer	8.79e-06	0.000328	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PIK3CB—pancreatic cancer	8.42e-06	0.000314	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PTGS2—pancreatic cancer	8.34e-06	0.000311	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PTEN—pancreatic cancer	7.28e-06	0.000271	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PIK3CA—pancreatic cancer	6.2e-06	0.000231	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PIK3CA—pancreatic cancer	5.13e-06	0.000191	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—AKT1—pancreatic cancer	5.07e-06	0.000189	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—AKT1—pancreatic cancer	4.19e-06	0.000156	CbGpPWpGaD
